SCHEMBL18470155

SCHEMBL18470155

O=C1c2ccc3c4c(c(O)cc(c24)C(=O)N1c1ccccc1)C(=O)N(c1ccccc1)C3=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ POLB P06746 4/20 0.53
▸ APAF1 O14727 1/20 0.53
▸ USP2 O75604 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ MAPT P10636 2/20 0.50
▸ HTT P42858 2/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ TNNI3 P19429 1/20 0.50
▸ TNNT2 P45379 1/20 0.50
▸ TNNC1 P63316 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ APOBEC3A P31941 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ CASP6 P55212 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26368699 0.81 ESR1 (0.47) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL18470143 0.81 HSPA1A (0.47) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL7491321 0.81 POLB (0.63) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL31167971 0.81 POLB (0.63) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL16601645 0.78 POLB (0.85) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL18470135 0.77 KMT2A (0.47) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL21841879 0.76 HSPA1A (0.51) ESR1NPC1RAB9APOLBUSP2
SCHEMBL12108015 0.76 KMT2A (0.54) ESR1POLBUSP2KMT2AMEN1
SCHEMBL29726032 0.74 ALDH1A1 (0.60) ESR1NPC1RAB9APOLBAPAF1
SCHEMBL7597251 0.74 ALDH1A1 (0.60) ESR1NPC1RAB9APOLBAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10596164-B2 Anti-clostridium compounds NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2020-03-24 — — US disclosed
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETEN SCHAPPELIJK ONDERZOEK TNO (NL) 2017-02-09 — — US disclosed
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETEN SCHAPPELIJK ONDERZOEK TNO (NL) 2017-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10596164-B2 Anti-clostridium compounds CLPP, ATP5F1A, ATP5F1C ESR1 4719/4885NPC1 4092/4885RAB9A 4710/4885
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS ANTXR2, CLPP, DAD1 ESR1 4725/4885NPC1 3998/4885RAB9A 4554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback